Showing results (61-70 of 310) with videos related to
Sort By:
Pageof 31
Journal of Palliative Medicine|January 4, 2018
Associations between Mild Cognitive Dysfunction and End-of-Life Outcomes in Patients with Advanced CancerKeiko Kurita, M Cary Reid, Eugenia L Siegler, et al.Ophthalmology. Retina|November 15, 2024
Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal InfiltratesJasmine H Francis, Anne S Reiner, Julia Canestraro, et al.Journal of Neuro-Oncology|May 31, 2014
Prognostic awareness and communication of prognostic information in malignant glioma: a systematic reviewEli L Diamond, Geoffrey W Corner, Antonio De Rosa, et al.Autoimmunity Reviews|August 22, 2006
Autoimmune aspects of chronic periaortitisAugusto Vaglio, Paolo Greco, Domenico Corradi, et al.Medicine|May 27, 2016
Erdheim-Chester Disease as a Mimic of IgG4-Related Disease: A Case Report and a Review of a Single-Center CohortDavide Gianfreda, Claudio Musetti, Maria Nicastro, et al.Human Pathology|September 3, 2004
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell deathDomenico Corradi, Augusto Vaglio, Roberta Maestri, et al.Acta Bio-Medica : Atenei Parmensis|August 11, 2007
Lung metastasectomy in patients with renal cell cancer (RCC). A 17-year experience in Parma HospitalStefania Ferretti, Samanta Fornia, Luca Ampollini, et al.Current Opinion in Rheumatology|November 22, 2013
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and managementAlfred Mahr, Frank Moosig, Thomas Neumann, et al.Acta Bio-Medica : Atenei Parmensis|October 16, 2004
"Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimenRoberto Giacosa, Rosaria Santi, Augusto Vaglio, et al.Oncology|December 3, 2008
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profileAugusto Vaglio, Federico Alberici, Umberto Maggiore, et al.Pageof 31